Key Highlights

  • Health care finished as the second-worst S&P 500 sector.
  • Humana was the S&P 500's worst performer.
  • UnitedHealth was the worst stock in the Dow.
  • The proposed CRUSH rule drove the insurer selloff.

Insurers lead the decline

Health care pushed the Dow Jones Industrial Average to its session low.

The heaviest losses came from managed-care companies. Humana (NYSE:HUM) was the worst performer in the S&P 500, and UnitedHealth Group (NYSE:UNH) was the worst stock in the Dow. Elevance Health (NYSE:ELV), Centene (NYSE:CNC) and CVS Health (NYSE:CVS) also tumbled. Cigna (NYSE:CI) and Molina Healthcare (NYSE:MOH) fell as well. It was the second straight day of declines for the group.

The Dow fell 561.25 points to 50,198.17, with UnitedHealth the biggest drag. The S&P 500 slipped 16.90 points to 7,323.63, its fifth straight loss.

The CRUSH rule

The catalyst was a proposed rule from the Centers for Medicare and Medicaid Services, released Monday, Nov. 16. CMS calls it "Comprehensive Regulations to Uncover Suspicious Healthcare," or CRUSH. It would allow the agency to extrapolate Medicare Advantage audit findings from a sample to an entire contract, extending the audit and overpayment lookback to payment year 2018.

CMS says the rule could save about $90 billion over 10 years. CMS Administrator Dr. Mehmet Oz framed it as a way to "crush fraud, waste, and abuse."

The rule is not final. Comments are due Jan. 19, 2027. It revives a 2023 Risk Adjustment Data Validation rule that a federal judge in Texas vacated in September 2025 in a case brought by Humana.

Why Humana and UnitedHealth were hit hardest

Medicare Advantage is the privately run alternative to traditional Medicare, and it has become a major Business for insurers. Humana is especially exposed: Medicare Advantage accounted for $99.4 billion of its $129.7 billion in 2025 revenue. UnitedHealth is the largest Medicare Advantage provider by enrollment.

One analyst said, "The substantially larger collection estimate reflects broader auditing," adding that CMS "could choose to make adjustments in the final rule." Oppenheimer expects legal challenges to the rule.

Sen. Elizabeth Warren also weighed in on X, saying UnitedHealth, CVS and Cigna "each own a health insurer, pharmacy middleman, and pharmacy" and "take a cut at every step."

Drugmakers drift lower

Pharmaceutical stocks added to the sector's losses. Merck (NYSE:MRK), Eli Lilly (NYSE:LLY), Johnson & Johnson (NYSE:JNJ) and Pfizer (NYSE:PFE) all declined, moving with the sector; no company-specific catalyst was confirmed for any of them. Smaller health names also fell, including Astrana Health (NASDAQ:ASTH), which moved with the managed-care selloff, and Ardent Health (NYSE:ARDT), which priced a secondary offering of 8 million shares at $14.50.

Insurer Selloff Leaves Health Care Searching for a Floor

The public comment period on the CRUSH rule runs through Jan. 19, 2027, and any changes CMS makes in the final version will be closely watched by insurers. UnitedHealth's management plans to provide its 2027 outlook before year-end. Investors will also track whether the rule faces court challenges, as Oppenheimer expects, though the outcome of any litigation cannot be predicted. Upcoming Medicare Advantage bid and enrollment updates could offer more clues on how plans adjust.